G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 66,000 | $95,040 | 0.00% |
| Citadel Advisors | 8,900 | $12,816 | 0.00% |
| Citadel Advisors | 140,818 | $202,778 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 264,600 | $381,024 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34,900 | $50,256 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 43,446 | $62,562 | 0.00% |
| Daiwa Securities Group Inc. | 145 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 17,480 | $25 | 0.00% |
| Providence Capital Advisors, LLC | 212 | $305 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 17,755 | $26 | 0.00% |
| CWM, LLC | 1,500 | $2 | 0.00% |
| JPMORGAN CHASE & CO | 9,360 | $13,478 | 0.00% |
| BARCLAYS PLC | 6,302 | $9 | 0.00% |
| ROYAL BANK OF CANADA | 90 | $0 | 0.00% |
| Allworth Financial LP | 750 | $1,080 | 0.00% |
| VANGUARD GROUP INC | 1,950,068 | $2,808,098 | 0.00% |
| FEDERATED HERMES, INC. | 3,274 | $4,715 | 0.00% |
| JANE STREET GROUP, LLC | 10,395 | $14,969 | 0.00% |
| Cubist Systematic Strategies, LLC | 21,359 | $30,757 | 0.00% |
| UBS Group AG | 213 | $307 | 0.00% |
External links
This page lists G1 THERAPEUTICS INC's shareholders in Q3 2023. To view G1 THERAPEUTICS INC's shareholder history, click here.